ONESOURCE SPECIALTY PHARMA
|
The Current P/S Ratio of ONESOURCE SPECIALTY PHARMA is 10.54.
| Share Price | ₹1,345.8 | Feb 27,2026 |
| Market Cap | ₹15,422.3 Cr | |
| Sales-TTM | ₹1,463.8 Cr | TTM-Standalone Results |
| Price/Sales | 10.54x | Calculated as Market Cap/Sales |
|---|---|---|
| Explore Stock Analytics | ||
Definition & Calculation of PS (Price/Sales) ratio of ONESOURCE SPECIALTY PHARMA
P/S =
Market Capitalization
/
Sales
or, using per-share numbers:
P/S = Stock Price / Sales Per Share
Current Market Cap [ ₹15,422.3 Cr] as on Feb 27,2026
(/) Sales [ ₹1,463.8 Cr] based on TTM-Standalone Results
(=) P/S Ratio [ 10.54x ]
Thus, for ONESOURCE SPECIALTY PHARMA , the investors are currently willing to pay '10.54 times sales' to own 1 share of the company.
PS Multiples are one of the most widely used valuation multiple in the industry.
P/S ratios can be a reliable benchmark to compare companies with negative earnings or book value.
You may also explore Price to Earnings ratio or Price to Book ratio of ONESOURCE SPECIALTY PHARMA !
The chart below summarizes the trend in P/S Ratio of ONESOURCE SPECIALTY PHARMA over the last five years.
Historical PS (Price/Sales) ratio chart of ONESOURCE SPECIALTY PHARMA
PS Ratio Performance Analysis for ONESOURCE SPECIALTY PHARMA
- ONESOURCE SPECIALTY PHARMA 's p/e ratio for fiscal years ending Mar2025 to Mar2023 averaged 5.13x.
- ONESOURCE SPECIALTY PHARMA 's operated at median p/e ratio of 0x from fiscal years ending March 2018 to 2022.
- Looking back at the last 3 fiscal years, ONESOURCE SPECIALTY PHARMA 's p/e ratio peaked in Mar2025 at 15.39x.
- ONESOURCE SPECIALTY PHARMA 's p/e ratio hit its five-year low in Mar2024 of 0x.
How does ONESOURCE SPECIALTY PHARMA 's P/S Ratio benchmark against top 10 peers in Pharmaceuticals & Drugs Industry?
| Peer Comparison (Pharmaceuticals & Drugs Industry) | Sales (Cr) | PS Ratio | Market Cap (Cr) |
|---|---|---|---|
| ONESOURCE SPECIALTY PHARMA | 1,463.8 | 10.54 | 15,422.3 |
| SUN PHARMACEUTICAL INDUSTRIES LTD | 56,809.1 | 7.34 | 417,028.0 |
| DIVIS LABORATORIES LTD | 10,314.0 | 16.51 | 170,237.0 |
| CIPLA LTD | 28,351.1 | 3.84 | 108,861.0 |
| TORRENT PHARMACEUTICALS LTD | 12,742.0 | 11.52 | 146,801.0 |
| DR REDDYS LABORATORIES LTD | 34,682.2 | 3.10 | 107,435.0 |
| MANKIND PHARMA LTD | 13,914.1 | 6.67 | 92,784.1 |
| ZYDUS LIFESCIENCES LTD | 26,089.3 | 3.56 | 92,825.1 |
| LUPIN LTD | 26,150.5 | 4.02 | 105,182.0 |
| AUROBINDO PHARMA LTD | 33,181.9 | 2.14 | 70,947.8 |
| ABBOTT INDIA LTD | 6,824.1 | 8.25 | 56,300.3 |
Pharmaceuticals & Drugs Industry Benchmark (Top 10) PS Analysis vs ONESOURCE SPECIALTY PHARMA 's P/S Ratio
| Top 10 Industry Peers | PS Ratio |
|---|---|
| Min industry PS | 2.14x |
| Max industry PS | 16.51x |
| Median industry PS | 6.67x |
| Average industry PS | 7.04x |
You may also like the below Video Courses